Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Allogene Therapeutics (ALLO) Return on Invested Capital (2019 - 2020)

Allogene Therapeutics (ALLO) has disclosed Return on Invested Capital for 2 consecutive years, with 0.22% as the latest value for Q3 2020.

  • Quarterly Return on Invested Capital changed N/A to 0.22% in Q3 2020 from the year-ago period, while the trailing twelve-month figure was 0.22% through Sep 2020, changed N/A year-over-year, with the annual reading at 0.59% for FY2024, N/A changed from the prior year.
  • Return on Invested Capital hit 0.22% in Q3 2020 for Allogene Therapeutics, up from 0.27% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.22% in Q3 2020 to a low of 0.36% in Q1 2020.